The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Retrospective study to assess the efficacy and safety of checkpoint inhibitors in advanced urothelial carcinoma in real-world setting.
 
Elena Sevillano Fernandez
Honoraria - Bristol-Myers Squibb; MSD; Roche
Consulting or Advisory Role - Roche
Speakers' Bureau - Bristol-Myers Squibb; MSD; Roche
Research Funding - Roche
Travel, Accommodations, Expenses - MSD; Pfizer; Roche
 
Javier Puente
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; Janssen-Cilag; MSD Oncology; Pfizer; Pierre Fabre; Roche; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Clovis Oncology; Eisai; Ipsen; Janssen-Cilag; Merck Sharp & Dohme; Pfizer; Roche; Sanofi
Research Funding - Astellas Pharma; Pfizer
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Janssen-Cilag; MSD Oncology; Pfizer; Roche
 
Natalia Vidal
Speakers' Bureau - Astellas Pharma; AstraZeneca; Eisai; Pfizer; Sanofi
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD Oncology; Pfizer; Pierre Fabre
 
Alvaro Pinto
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Ipsen; Janssen Oncology; MSD Oncology; Novartis; Pfizer; Pierre Fabre; Roche; Sanofi/Aventis
Research Funding - Bristol-Myers Squibb; Bristol-Myers Squibb; Pfizer
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Janssen; Pfizer; Roche
 
Lourdes Garcia Sanchez
No Relationships to Disclose
 
Aldo Fiorini
No Relationships to Disclose
 
Luis Enrique Chara Velarde
No Relationships to Disclose
 
Irene Nalda Ariza
No Relationships to Disclose
 
Javier Cassinello
No Relationships to Disclose
 
Angel Rodriguez
No Relationships to Disclose
 
Saray Galvan Ruiz
No Relationships to Disclose
 
Juan Francisco Rodriguez-Moreno
No Relationships to Disclose
 
Arantzazu Barquin
No Relationships to Disclose
 
Sergio Ruiz
No Relationships to Disclose
 
Paloma Navarro
No Relationships to Disclose
 
Monica Yagüe
No Relationships to Disclose
 
Enrique Grande
Honoraria - Advanced Accelerator Applications; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Celgene; Eisai; Eusa Pharma; Genzyme; IPSEN; Janssen-Cilag; Lexicon; Lilly; MSD; Novartis; Pfizer; Pierre Fabre; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Ipsen; MSD; Pfizer; Roche; Roche
Research Funding - AstraZeneca (Inst); Ipsen (Inst); Molecular Templates (Inst); Pfizer (Inst); Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Janssen-Cilag; Pfizer; Roche/Genentech
 
Jesús García-Donas
Consulting or Advisory Role - Bristol-Myers Squibb; Clovis Oncology
Speakers' Bureau - Amgen; AstraZeneca; Bristol-Myers Squibb; Clovis Oncology; GlaxoSmithKline; Janssen-Cilag; PharmaMar; Roche
Research Funding - AstraZeneca; Bristol-Myers Squibb; GamaMabs Pharma; InvitroCue; Merck; Pfizer; Roche
Travel, Accommodations, Expenses - Roche